Marques Skot Neilson, DO in Flagstaff, AZ - Medicare Student in an Organized Health Care Education/Training Program

Marques Skot Neilson, DO is a medicare enrolled "Student In An Organized Health Care Education/training Program" physician in Flagstaff, Arizona. His current practice location is 2920 N 4th St, Flagstaff, Arizona. You can reach out to his office (for appointments etc.) via phone at (928) 522-9400.

Marques Skot Neilson is licensed to practice in Arizona (license number R4167) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1912574377.

Contact Information

	Marques Skot Neilson, DO
	2920 N 4th St, Flagstaff, AZ 86004-1816
	(928) 522-9400
	Not Available

Physician's Profile

Full Name	Marques Skot Neilson
Gender	Male
Speciality	Student In An Organized Health Care Education/training Program
Location	2920 N 4th St, Flagstaff, Arizona
Accepts Medicare Assignments	Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.

NPI Data:

NPI Number: 1912574377
Provider Enumeration Date: 06/04/2021
Last Update Date: 02/26/2024

Medicare PECOS Information:

PECOS PAC ID: 9133517105
Enrollment ID: I20211025000179

Medical Identifiers

Medical identifiers for Marques Skot Neilson such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1912574377	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207Q00000X	Family Medicine	OT020864 (Pennsylvania)	Secondary
208D00000X	General Practice	010846 (Arizona)	Secondary
390200000X	Student In An Organized Health Care Education/training Program	R4167 (Arizona)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Marques Skot Neilson is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Marques Skot Neilson, DO 2920 N 4th St, Flagstaff, AZ 86004-1816 Ph: (928) 522-9400	Marques Skot Neilson, DO 2920 N 4th St, Flagstaff, AZ 86004-1816 Ph: (928) 522-9400

News Archive

ImmunoCellular Therapeutics presents additional data from its ICT-107 Phase I clinical trial

ImmunoCellular Therapeutics, Ltd., a biotechnology company that is focused on the development of novel immune-based cancer therapies, today announced additional data from its Phase I clinical trial evaluating ICT-107, the Company's dendritic-cell based cancer vaccine product candidate for the treatment of glioblastoma multiforme (GBM).

Genetically engineered animals help in scientific research that may benefit children

The recent use of genetically modified mice and rats in combination with an animal model of obstructive nephropathy, a type of renal disease, has given researchers new insight in the development of kidney disease.

Lung cancer patients should be screened for MET oncogene amplification, research suggests

Research by investigators at Mayo Clinic Cancer Center suggests that physicians should screen patients with lung cancer for MET amplification/overexpression before determining a treatment strategy.

CD8+ Tregs can remove pathogenic T cell subsets and inhibit progression of RA

Rheumatoid arthritis (RA) is an autoimmune disorder in which immune cells attack the joints, causing inflammation, swelling, and erosion. Specific sets of immune cells, known as T cells, are responsible for inducing disease. In this issue of the Journal of Clinical Investigation, researchers led by Harvey Cantor at Harvard University analyzed the contributions of different subsets of T cells to an RA-like condition in mice.

New mutations in the estrogen receptor drive strong drug resistance exhibited by human breast tumors

Human breast tumors transplanted into mice are excellent models of metastatic cancer and are providing insights into how to attack breast cancers that no longer respond to the drugs used to treat them, according to research from Washington University School of Medicine in St. Louis.

Marques Skot Neilson, DO - Medicare Student in an Organized Health Care Education/Training Program in Flagstaff, AZ